CD8A and small cell lung carcinoma: It is suggested that the incorporation of the assessment of SCLC subtypes and CD8 cell infiltration into the SCLC treatment protocol involving ICI could offer substantial benefits to patients with SCLC and potentially lead to favorable medical economics.